The present study aimed to determine the effects of the broad-spectrum matrix metalloproteinase and TACE-inhibitor Marimastat on hepatic steatosis and insulin resistance in murine models of diet-induced obesity and leptin deficiency. The gene discussed is ADAM17; the disease is Hepatic steatosis.